NASDAQ · Biotechnology

CorMedix Inc. (CRMD) Stock

$7.85 -3.09% NASDAQ: CRMD Healthcare

Valuation

MetricValue
Price$7.85
Market Cap$611.86M
P/E Ratio3.01
P/B Ratio1.24
P/S Ratio1.23
EPS (TTM)$0.00
52-Week High$13.02
52-Week Low$6.13
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE44.64%
ROA20.70%
ROCE30.29%
Gross Margin85.83%
Operating Margin48.41%
Net Margin40.49%
Debt/Equity0.31
Current Ratio2.11

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$43.0M$312.0M
Operating Profit$-29.0M$-31.0M$-49.0M$-22.0M$150.0M
Net Profit$-28.0M$-30.0M$-46.0M$-18.0M$163.0M
EPS$-0.75$-0.74$-0.91$-0.30$2.04
Op Margin-15417.5%-46819.9%—-51.4%48.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$69.0M$62.0M$82.0M$119.0M$826.0M
Total Liabilities$6.0M$7.0M$12.0M$34.0M$421.0M
Cash$53.0M$43.0M$44.0M$41.0M$146.0M
Borrowings$1.0M$1.0M$1.0M$1.0M$149.0M

Latest News

Nurix Therapeutics, Inc. (NRIX) Reports Q2 Loss, Lags Revenue Estimates Zacks · Jul 9, 2026 Exelixis, Inc. (EXEL) Hit a 52 Week High, Can the Run Continue? Zacks · Jul 8, 2026 RBC Capital Trims CorMedix Price Target to $13 From $14, Maintains Outperform Rating MT Newswires · Jul 7, 2026 CorMedix Names Elizabeth Hurlburt as Chief Operating, Commercial Officer MT Newswires · Jul 2, 2026 CRMD's Growth Story Expands Beyond DefenCath Into New Trends Zacks · Jun 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-21.0M$-24.0M$-38.0M$-51.0M$175.0M
Investing Cash Flow$-11.0M$-4.0M$-17.0M$21.0M$-311.0M
Financing Cash Flow$0$0$0$0$-8.0M
Net Cash Flow$11.0M$-10.0M$0$-3.0M$105.0M
Free Cash Flow$-23.0M$-25.0M$-39.0M$-51.0M$173.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA1.84
FCF Yield44.19%
Quick Ratio2.36
Interest Coverage78.49
Return 1Y-30.72%
Return 3Y110.73%
Return 5Y24.92%

Ownership

Insiders Held7.53%
Institutions Held54.74%
Institutions Float Held59.19%
Institutional HolderSharesReport Date
Deep Track Capital, Lp6,274,0762026-03-31
Blackrock Inc.5,967,5752026-03-31
Vanguard Capital Management LLC3,129,6562026-03-31
State Street Corporation2,191,8432026-03-31
Royce & Associates LP1,887,5322026-03-31

About CorMedix Inc.

CorMedix Inc. is led by CEO Joseph Todisco, employs 64 people, headquartered in US, publicly traded since 2010.

CorMedix Inc. (CRMD) stock trades at $7.85 with a market capitalization of $611.86M. The stock is valued at a price-to-earnings (P/E) ratio of 3.01, price-to-book of 1.24, price-to-sales of 1.23. Over the past 52 weeks the stock has ranged between $6.13 and $13.02, and currently trades 39.7% below its 52-week high.

On profitability, CorMedix Inc. generates a return on equity (ROE) of 44.64%, above the typical market range of roughly 12-15%, return on capital employed of 30.29%, an operating margin of 48.41%, a net profit margin of 40.49%.

CorMedix Inc. by the numbers, 2016–2025

Between 2016 and 2025 CorMedix Inc. reported revenue of $0 rising to $312.0M. Compounded, revenue has grown —% a year over five years, —% over three, 625.6% over the last twelve months. Net profit rose to $163.0M.

Operating margin went from -11048.8% in 2016 to 48.2% in 2025, a gain of 11097.0 percentage points. The most recent net margin is 40.49%. On a trailing twelve-month basis to Jun '26, revenue is $462.0M and net profit $188.0M.

Borrowings stand at $149.0M, cash from operations was $175.0M in the latest year, positive in 1 of the last 10.

Return on equity has averaged -29.1% over five years, and was 40.3% in the most recent year.

The share price itself has compounded at 1.0% a year over five years, 18.7% over three, -41.2% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

CorMedix Inc. (CRMD) — frequently asked questions

What is CorMedix Inc. (CRMD) stock price today?

CorMedix Inc. (CRMD) is currently trading at $7.85, down 3.09% today.

What is CRMD P/E ratio?

CorMedix Inc.'s P/E ratio is 3.01. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.

What is CRMD return on equity (ROE)?

CorMedix Inc.'s return on equity (ROE) is 44.64%. ROE measures net income relative to shareholders' equity. This is above the typical market range of roughly 12-15%.

What is CorMedix Inc.'s market cap?

CorMedix Inc. has a market capitalization of $611.86M.

Does CRMD pay a dividend?

CorMedix Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does CRMD carry?

CorMedix Inc. has a debt-to-equity ratio of 0.31. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is CRMD's profit margin?

CorMedix Inc. reports a net profit margin of 40.49% — the share of revenue left after every cost, including tax and interest.

What sector is CRMD in?

CorMedix Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is CRMD listed on?

CorMedix Inc. trades on NASDAQ under the ticker CRMD.

What is CRMD's 52-week range?

Over the last year CorMedix Inc. has traded between $6.13 and $13.02.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens CRMD currently matches

On the figures above, CorMedix Inc. passes the filters for 22 of our ready-made screens, among them Low PE Stocks, Small Cap Stocks, Stocks Under $10. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Low PE StocksSmall Cap StocksStocks Under $10Stocks With PE Under 20Small Cap Low PE StocksStocks With PE Under 10Stocks With PE Under 5High ROCE StocksStocks Under $100Stocks Under $50Small Cap Value StocksGraham-Style Defensive StocksHigh Gross Margin StocksHigh ROCE Low PE StocksLow PE High ROE StocksProfitable Small Cap StocksStocks With PE Under 25Stocks With PE Under 30High ROE Stocks Under $100Debt to Equity Below 1 StocksLow PE and PB StocksHigh Current Ratio Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.